Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," ...

Vir Biotechnology lands a license agreement with Japan’s Astellas Pharma for its lead drug candidate.

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

The average age of men who get diagnosed is 67.

There may be a "promising new strategy" in combating aggressive forms of prostate cancer, according to a new study. Researchers at Flinders University and the University of South Australia ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...

Relief for men experiencing the challenges of Benign Prostatic Hyperplasia (BPH), or prostate enlargement, has arrived with the introduction of Flowel and Flowel Plus by Superior Pharmaceuticals ...

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

Bayer sued rival Johnson & Johnson for launching a “false advertising campaign” based on flawed data to wrongfully promote ...

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S.